000 02911cam a2200349 a 4500
003 EG-GiCUC
005 20250223032537.0
008 200805s2020 ua dh f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aPh.D
099 _aCai01.10.13.Ph.D.2020.Mo.A
100 0 _aMohamed Ahmed Elsharkawi
245 1 0 _aAutologous bone marrow derived mesenchymal stem cells (MSCS)therapy for tendon repair in equines /
_cMohamed Ahmed Elsharkawi ; Supervised Mohamed M. Shokry , Ayman A. Mostafa , Adel F. Tohamy
246 1 5 _aالخلايا الجذعية الذاتية فى إلتئام إصابات الأوتار فى الخيل
260 _aCairo :
_bMohamed Ahmed Elsharkawi ,
_c2020
300 _a108 P. :
_bcharts , facsimiles ;
_c25cm
502 _aThesis (Ph.D.) - Cairo University - Faculty of Veterinary Medicine - Department of Surgery, Anesthesiology and Radiology
520 _aThe present study comprised 2 phases; the first phase was to experimentally evaluate the effect of autologous bone marrow-derived mesenchymal stem cells (MSCs), in healing of collagenase-induced SDFT tendon lesions in horse. The horses were clinically, ultrasonographically and morphohistologically evaluated at 2, 4, 8, 12 &16 weeks. Results proved the potential of autologous MSCs to accelerating tendon repair in terms of quality and time. The success of treatment was proven by the shortened rehabilitation time and the higher returning to athletic activity. The second phase was to apply and evaluate the therapeutic effect of autologous mesenchymal stem cells (MSCs) studied in the experimental phase on athletic horses affected with acute superficial digital flexor tendonitis. A total of 15 mixed breed athletic horses confirmed to have acute tendonitis of SDFT were included. Bone marrow was then harvested from the sternum of each horse using Jamshidi biopsy needle for MSCs isolation and culture. Auto implantation of a single dose of MSCs (1 ml, 10 {u00D7}106 cells) into the core lesion of each affected tendon was performed under US guidance after thorough aseptic preparation.The horses were subjected to a rehabilitation program until the end of the follow-up period (8 weeks). Clinical and ultrasonographic findings were satisfactory after 8 weeks of MSCs therapy. In conclusion autogenous MSCs therapy has proven to have a reparative effect on acute tendonitis since the majority of treated patients (66.7 %) have returned to athletic activity
530 _aIssued also as CD
653 4 _aBone Marrow
653 4 _aMesenchymal
653 4 _aMSCS
700 0 _aAdel F. Tohamy ,
_eSupervisor
700 0 _aAyman A. Mostafa ,
_eSupervisor
700 0 _aMohamed M. Shokry ,
_eSupervisor
856 _uhttp://172.23.153.220/th.pdf
905 _aNazla
_eRevisor
905 _aShimaa
_eCataloger
942 _2ddc
_cTH
999 _c77090
_d77090